Phaseline

Targets › TAURINE

TAURINE: drug programs, companies and trials

1 program from 1 company in 1 trial: 1 Phase 2; Immunology; next expected readout Dec 2026.

Open in Phaseline: the race on TAURINE, likelihood bands and readouts

Programs

CompanyDrugTargetsHighest phaseConditionsNext expected readout
Hospital de Clinicas de Porto AlegreTaurine
Semi-essential amino acid with antioxidant and osmoregulatory properties
TAURINEPhase 2Diabetes Mellitus, Type 2Dec 2026

Conditions

Diabetes Mellitus, Type 2 (1)

Modalities

small molecule (1)

Companies

Hospital de Clinicas de Porto Alegre (1)

Related targets

–

Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.